发明授权
EP1874781B1 DIHYDROTHIENOPYRIMIDINE ZUR BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN
有权
Dihydrothienopyrimidines炎症性疾病的治疗
- 专利标题： DIHYDROTHIENOPYRIMIDINE ZUR BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN
- 专利标题（英）： Dihydrothienopyrimidines for the treatment of inflammatory diseases
- 专利标题（中）： Dihydrothienopyrimidines炎症性疾病的治疗
-
申请号： EP06743350.8申请日： 2006-04-19
-
公开(公告)号： EP1874781B1公开(公告)日： 2009-06-24
- 发明人: POUZET, Pascale , HOENKE, Christoph , MARTYRES, Domnic , NICKOLAUS, Peter , JUNG, Birgit
- 申请人： Boehringer Ingelheim International GmbH , Boehringer Ingelheim Pharma GmbH & Co. KG
- 申请人地址： Binger Strasse 173 55216 Ingelheim am Rhein DE
- 专利权人： Boehringer Ingelheim International GmbH,Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人： Boehringer Ingelheim International GmbH,Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人地址： Binger Strasse 173 55216 Ingelheim am Rhein DE
- 代理机构： Hammann, Heinz
- 优先权： DE102005019201 20050421
- 国际公布： WO2006111549 20061026
- 主分类号： C07D495/04
- IPC分类号： C07D495/04 ; A61P11/00 ; A61K31/519
摘要：
The invention relates to novel dihydrothienopyrimidines of formula (1) as well as pharmaceutically acceptable salts, diastereomers, enantiomers, racemates, hydrates, or solvates thereof, which are suitable for the treatment of ailments or diseases of the respiratory tract, gastrointestinal ailments or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system, or cancer diseases. Also disclosed are pharmaceutical compositions containing the inventive compounds.
公开/授权文献
信息查询
